and recommended for use. Overall,
therapies for CI in PD have been inadequately investigated, making it necessary
ДЕПРЕССИЯ И ТРЕВОЖНОСТЬ ПРИ БОЛЕЗНИ ПАРКИНСОНААхмадеева, Г.Н.,
Магжанов, Р.В.,
Таюпова, Г.Н.,
Байтимеров, А.Р.,
Хидиятова, И.М.,
Akhmadeeva, G.N.,
Magzhanov, R.V.,
Tayupova, G.N.,
Bajtimerov, A.R.,
Hidijatova, I.M. (2017) of anxiety. In
general, methods of
therapy of anxiety and depressive disorders in PD are not well understood
YUE, E.,
TUGUZBAEVA, G.M.,
CHEN, X.,
LI, A.,
SUN, X.,
DONG, C.,
LIU, Y.,
YU, Y.,
ZAHRA, S.M.,
JIANG, Y.,
BAI, Y.,
QIN, Y.,
SHAN, Q.,
DU, Z. (2019) of anthocyanin on oral squamous cell carcinoma and identify effective targets for
therapy. Methods: Cellviability
Karasev, S.M.,
Sufianov, A.A.,
Khafizov, R.R.,
Karaseva, I.I.,
Shugushev, Z.K.,
Maximkin, D.A.,
Khafizov, T.N. (2021) -stage
therapy throughout life. The article presents a clinical case of successful endovascular treatment
receiving antidepressant
therapy, there is an urgent need for developing novel agents with antidepressant
related to retroelements was described. These results are promising for targeted disease
therapyGareev, Ilgiz,
Aamir, Ahmad,
Jiaqi, Wang,
Aferin, Beilerli,
Tatiana, Ilyasova,
Albert, Sufianov,
Ozal, Beylerli (2023)
in the GC preventive, diagnosis, prognosis and monitoring
therapySavelieva, Olga,
Karunas, Alexandra,
Prokopenko, Inga,
Balkhiyarova, Zhanna,
Gilyazova, Irina,
Khidiyatova, Irina,
Khusnutdinova, Elza (2025) and respective response to drug
therapy. PGS models could help to predict the individual risk of asthma using 26
for comprehensive clinical trials to establish the efficacy of polyphenol-based
therapies targeting nc